BIT's 15th Annual Congress of International Drug Discovery Science and Technology - Japan 2017 (IDDST-Japan 2017)
★ Scientific Program

BIT's 15th Annual Congress of

International Drug Discovery Science and Technology - Japan 2017

Theme: Dedicated to Accelerating Drug Innovation

Time: July 25-27, 2017

Venue: Osaka, Japan

 

Keynote Forum Scientific Program
Section 1 Section 2 Section 3 Section 4 Section 5 Section 6 Young Scientist Forum

 

Opening Ceremony and Keynote Forum

Sponsored by ReproCELL Group Companies

Day 1: Morning, Tuesday, July 25, 2017
09:00-12:00
Place: Crystal & Ruby, 2F, Banquet Tower, HRO

Moderator: Dr. Shu-Hui Liu, Director, Pfizer Inc., USA
Time FaceOn Speeches and Speakers Org. Logo
09:00-09:10 Opening Remark
09:10-09:40 Title: Catalytic Asymmetric C–C Bond Formation with 1-Alkenes of One-Point Binding: ZACA Reaction. Its Discovery and Recent Development
Dr. Ei-ichi Negishi,
H. C. Brown Distinguished Professor of Chemistry, Purdue University, USA
2010 Nobel Prize Laureate in Chemistry
09:40-10:05 Title: Plasma Metabolomic Profiles and Alzheimer’s Disease
Dr. Howard J. Federoff,
Vice Chancellor of Health Affairs and Chief Executive Officer of Health System, University of California, Irvine, USA
10:05-10:30 Title: The Changing Face of Science and Technology Innovation
Dr. Litao Zhang,
Vice President, Leads Discovery and Optimization, Bristol-Myers Squibb, USA
10:30-10:55 Title: Innovation Outsourcing in Pharmaceutical Research: The Emergence of New Industrial Players that Change the Early Discovery Landscape
Dr. Jan Hoflack,
Chief Scientific and Operational Officer, Oncodesign SA, France
10:55-11:20 Title: Resolute Improvement of Drug Screening System and Application of Combination of Classic and Newly Developed Technologies to Several Projects Contributing to Drug Development at Clinical Stage
Dr. Akiyoshi Suganuma,
Group Officer and President of BA-CFU, Medicine Development Center, Eisai Co., Ltd., Japan
11:20-12:00 Sponsor
Title:
Improving the Prediction of Clinical Safety, ADME and Efficacy by the Use of Human Fresh Tissues, 3D Models and Stem Cells
Dr. David C. Bunton,
CEO, REPROCELL Europe Ltd., UK
12:00-13:30 Lunch

 

Hosting Organization
whtslogo.JPG
World High Technology Society
Operating Organization
BIT Group Global Ltd.
Supporting Organizations

Keio University School of Medicine, Japan

Nagoya University Graduate School of Pharmaceutical Sciences, Japan

Shenzhen International Institute for Biomedical Research, China

Official Travel Agency
Media Partners

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2016-2017 BIT Group Global Ltd.